Overview
ISO 5058-1:2021 is the foundational international standard focused on establishing a consistent vocabulary for genome editing within biotechnology. Developed by the International Organization for Standardization (ISO) Technical Committee ISO/TC 276, this standard defines terms commonly used in genome editing technology, ensuring a unified language for global stakeholders across multiple sectors. The vocabulary is applicable to genome editing applications across all species, supporting effective communication, data interpretation, and technology development.
Genome editing is a transformative technology allowing targeted, site-specific modification of nucleic acids-DNA or RNA-within an organism’s genome. With applications from human cell-based therapies to agriculture, standardizing terminology is critical for safety, reproducibility, and collaboration in research, regulatory, and commercial contexts.
Key Topics
ISO 5058-1:2021 organizes terminology into the following core categories:
- Genome Editing Concepts: Definitions of fundamental terms such as genome editing, gene editing, genome engineering, off-target effects, specificity, and target sequences.
- Genome Editing Tools: Vocabulary for general tools and technology-specific terms, including:
- General tools: Repair templates, site-directed DNA modification enzymes, and nucleases.
- CRISPR: Terms like Cas nuclease, guide RNA (gRNA), protospacer adjacent motif (PAM), single-guide RNA (sgRNA), tracrRNA, and RNP.
- Meganucleases, TALENs, and ZFNs: Definitions specific to each editing technology, including target sites, linkers, and protein structures.
- Genome Editing Outcomes: Terms related to the results of genome editing, such as edit, indel (insertion or deletion mutations), intended edit, unintended edit, homology-directed repair (HDR), non-homologous end joining (NHEJ), and microhomology-mediated end joining (MMEJ).
- Abbreviated Terms: Key acronyms and initialisms used throughout the field, such as DNA, RNA, CRISPR, TALE, and ZFN.
Applications
Standardizing genome editing terminology through ISO 5058-1:2021 has substantial value for a wide variety of practical applications:
- Research and Development: Facilitates precise and unambiguous communication among multidisciplinary teams working on innovative genome editing projects.
- Regulatory Compliance: Supports clear documentation and reporting for regulatory submissions, ethics reviews, and safety assessments by establishing recognized definitions.
- Biotechnology Industry: Promotes interoperability and harmonization between technology providers, developers, and users in areas such as gene therapy, biomanufacturing, synthetic biology, and agricultural biotechnology.
- Data Interpretation and Reporting: Enhances reproducibility and reliability of scientific findings by reducing ambiguity in published results, protocols, and data sets.
- Education and Training: Serves as an authoritative reference for academia, training programs, and industry onboarding, ensuring consistent educational outcomes.
Related Standards
For specialized or advanced applications, users of ISO 5058-1:2021 may consult additional ISO standards and resources, including:
- ISO/TC 34/SC 16: Focusing on horizontal methods for molecular biomarker analysis, often applied in food and agricultural biotechnology.
- ISO/TC 215: Providing standards for health informatics and related data exchange in clinical, diagnostic, and therapeutic applications.
- ISO 5058 Series: Comprehensive reference for future parts providing deeper guidance on genome editing processes and methods.
By aligning vocabulary and concepts, ISO 5058-1:2021 serves as an essential resource for all stakeholders in the rapidly evolving field of genome editing, driving better communication, innovation, and safety across biotechnological disciplines.
